ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2013

Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain.

Xiaohui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.